DRIO (DarioHealth) Moat Score: 4/10 (As of Jul. 03, 2026)


DRIO DarioHealth Corp DRIO
58 GF Score
Price $7.26
GF Value $7.10
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is DarioHealth Moat Score?

DarioHealth DRIO +7.85% 58 Moat Score is 4 as of Jul. 03, 2026. GuruFocus rates DRIO with a GF Score™ of 58/100 and a GF Value™ of $7.10 (Fairly Valued). The stock has 4 warning signs investors should review. Among 679 Healthcare Providers & Services companies, DarioHealth ranks better than 89.69% on this metric.

DarioHealth has the Moat Score of 4, which implies that the company might have Narrow Moat - Discernible but modest moat.

DarioHealth has Narrow Moat: DarioHealth has a discernible moat with its digital health solutions and some proprietary technology. It benefits from innovation and R&D capabilities, but lacks strong brand strength, significant customer switching costs, or regulatory barriers to establish a wider moat.

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes DarioHealth might have Narrow Moat - Discernible but modest moat.

DarioHealth  (NAS:DRIO) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

DarioHealth Moat Score Related Terms

DRIO vs BEAT, ONMD, CRVW: Moat Score Comparison

For the Health Information Services subindustry, DarioHealth's Moat Score, along with its competitors' market caps and Moat Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

DarioHealth Moat Score vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, DarioHealth's Moat Score distribution charts can be found below:

* The bar in red indicates where DarioHealth's Moat Score falls into.


DRIO
58GF Score
DarioHealth Corp DRIO
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Moat Score →
What does a Moat Score of 4 mean?
DarioHealth (DRIO) has a Moat Score of 4 as of Jul. 03, 2026. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. According to the industry distribution chart, DarioHealth ranks #70 out of 679 companies in the Healthcare Providers & Services industry, placing it in the top 10.3%.
Is DarioHealth's Moat Score too high?
DarioHealth's current Moat Score is 4. Based on the distribution chart, DarioHealth ranks #70 out of 679 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, DarioHealth has a GF Score™ of 58/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does DarioHealth's Moat Score compare to BEAT and ONMD?
According to the Healthcare Providers & Services industry distribution chart, DarioHealth ranks #70 out of 679 companies for Moat Score. This places DarioHealth in the top 10% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Moat Score for a Healthcare Providers & Services company?
A good Moat Score depends on the Healthcare Providers & Services industry context. However, Moat Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Moat Score mean?
A high Moat Score can signal that a stock is expensive relative to its fundamentals. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. DarioHealth's current Moat Score is 4. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is DarioHealth stock overvalued right now?
Based on GuruFocus' analysis, DarioHealth (DRIO) is currently considered Fairly Valued. The stock's GF Value™ is $7.10, compared to a current price of $7.26 — trading 2.2% above its estimated fair value. The current Moat Score is 4. DarioHealth's overall GF Score™ is 58/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Moat Score calculated?
Moat Score is calculated from a company's financial statements. For DarioHealth (DRIO), the current Moat Score is 4 as of Jul. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is DarioHealth (DRIO) Overvalued in 2026?

Based on GuruFocus' analysis, DarioHealth stock appears to be overvalued. The current stock price of $7.26 is trading 2.2% above its estimated GF Value™ of $7.10. GuruFocus considers DarioHealth to be Fairly Valued.

Key valuation signals for DRIO:

  • Moat Score: 4
  • GF Value™: $7.10 vs. price of $7.26 (2.2% above fair value)
  • GF Score™: 58/100 with 4 warning signs

No single metric tells the full story. See the DRIO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

DarioHealth Business Description

Address 322 West 57th Street, New York, NY, USA, 10019
DarioHealth Corp is a digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by precision data analytics, software, and personalized coaching. The company vertically integrated a health intelligence platform with a mission to power the behavior changes that drive greater health. Unlike software-only digital health platforms, Dario owns the complete chain of value in chronic care management - connected FDA-cleared hardware devices that generate continuous physiological data, and AI built on that proprietary data. The company focuses on delivering user experiences, longer sustained engagement, and stronger clinical outcomes, at affordable prices, which then delivers the highest return on investment in the industry.
58GF Score

Get the complete analysis for DRIO

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$7.26
Price
$7.10
GF Value